Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lucid Colloids is an Indian specialty ingredients and hydrocolloids manufacturer that produces, markets, and distributes natural and modified guar gum and related hydrocolloid derivatives. The company serves multiple end markets including food and beverage, pharmaceuticals, nutraceuticals, home and personal care, pet food, and industrial applications. In healthcare-related markets, Lucid supplies pharmaceutical and nutrition excipients such as guar gum, xanthan gum, pectin, carrageenan, and carboxymethyl cellulose for use in formulations including tablets and syrups. The business appears to be a commercial-stage ingredient supplier rather than a therapeutic drug developer, with manufacturing operations in India and overseas subsidiaries in the United States and Europe. Lucid traces its origins to Indian Gum Industries, established in 1958, and operates with in-house R&D, quality, and application development capabilities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Lucid Colloids.